{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:26:52Z","timestamp":1787239612770,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005006","name":"Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea","doi-asserted-by":"crossref","award":["2023IP0123"],"award-info":[{"award-number":["2023IP0123"]}],"id":[{"id":"10.13039\/501100005006","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Elimination of Cancer Project Fund, Asan Cancer Institute of Asan Medical Center, Seoul, Korea","award":["2024IP0100"],"award-info":[{"award-number":["2024IP0100"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-87838-3","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T07:37:03Z","timestamp":1738049823000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Risk of second primary malignancies among survivors of cutaneous melanoma: A nationwide population-based study in the Republic of Korea"],"prefix":"10.1038","volume":"15","author":[{"given":"Joon Min","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do Hyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye-Jee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ik Jun","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Eun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong Hyun","family":"Won","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,28]]},"reference":[{"key":"87838_CR1","doi-asserted-by":"publisher","first-page":"937","DOI":"10.4143\/crt.2021.871","volume":"54","author":"T Kim","year":"2022","unstructured":"Kim, T. et al. Incidence and survival rates of cutaneous melanoma in South Korea using nationwide health insurance claims data. Cancer Res. Treat. 54, 937\u2013949. https:\/\/doi.org\/10.4143\/crt.2021.871 (2022).","journal-title":"Cancer Res. Treat."},{"key":"87838_CR2","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.jaad.2007.06.032","volume":"57","author":"AC Geller","year":"2007","unstructured":"Geller, A. C., Swetter, S. M., Brooks, K., Demierre, M. F. & Yaroch, A. L. Screening, early detection, and trends for melanoma: Current status (2000\u20132006) and future directions. J. Am. Acad. Dermatol. 57, 555\u2013572. https:\/\/doi.org\/10.1016\/j.jaad.2007.06.032 (2007). quiz 573\u2009\u2013\u2009556.","journal-title":"J. Am. Acad. Dermatol."},{"key":"87838_CR3","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/CMR.0b013e3282fafd0a","volume":"18","author":"E Crocetti","year":"2008","unstructured":"Crocetti, E. et al. The risk of developing a second, different, cancer among 14 560 survivors of malignant cutaneous melanoma: A study by AIRTUM (the Italian Network of Cancer registries). Melanoma Res. 18, 230\u2013234. https:\/\/doi.org\/10.1097\/CMR.0b013e3282fafd0a (2008).","journal-title":"Melanoma Res."},{"key":"87838_CR4","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.jaad.2009.07.039","volume":"62","author":"JP Spanogle","year":"2010","unstructured":"Spanogle, J. P., Clarke, C. A., Aroner, S. & Swetter, S. M. Risk of second primary malignancies following cutaneous melanoma diagnosis: A population-based study. J. Am. Acad. Dermatol. 62, 757\u2013767. https:\/\/doi.org\/10.1016\/j.jaad.2009.07.039 (2010).","journal-title":"J. Am. Acad. Dermatol."},{"key":"87838_CR5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jaad.2011.04.033","volume":"65","author":"A Balamurugan","year":"2011","unstructured":"Balamurugan, A. et al. Subsequent primary cancers among men and women with in situ and invasive melanoma of the skin. J. Am. Acad. Dermatol. 65, 69\u201377. https:\/\/doi.org\/10.1016\/j.jaad.2011.04.033 (2011).","journal-title":"J. Am. Acad. Dermatol."},{"key":"87838_CR6","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1001\/archdermatol.2010.2","volume":"146","author":"PT Bradford","year":"2010","unstructured":"Bradford, P. T., Freedman, D. M., Goldstein, A. M. & Tucker, M. A. Increased risk of second primary cancers after a diagnosis of melanoma. Arch. Dermatol. 146, 265\u2013272. https:\/\/doi.org\/10.1001\/archdermatol.2010.2 (2010).","journal-title":"Arch. Dermatol."},{"key":"87838_CR7","doi-asserted-by":"publisher","first-page":"498","DOI":"10.25259\/IJDVL_601_19","volume":"87","author":"JM Jung","year":"2021","unstructured":"Jung, J. M. et al. Different progression pattern between acral and nonacral melanoma: A retrospective, comparative, clinicoprognostic study of 492 cases of primary cutaneous melanoma according to tumor site. Indian J. Dermatol. Venereol. Leprol. 87, 498\u2013508. https:\/\/doi.org\/10.25259\/IJDVL_601_19 (2021).","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"87838_CR8","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.pathol.2020.06.011","volume":"52","author":"JM Jung","year":"2020","unstructured":"Jung, J. M. et al. Lymphatic invasion in acral and non-acral melanoma: A comparative, clinicoprognostic study of primary cutaneous melanoma according to tumour site. Pathology 52, 670\u2013675. https:\/\/doi.org\/10.1016\/j.pathol.2020.06.011 (2020).","journal-title":"Pathology"},{"key":"87838_CR9","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.jaad.2023.12.064","volume":"90","author":"ME Choi","year":"2024","unstructured":"Choi, M. E. et al. Baseline serum neutrophil-to-lymphocyte ratio in acral melanoma compared with nonacral melanoma and its prognostic significance. J. Am. Acad. Dermatol. 90, 977\u2013985. https:\/\/doi.org\/10.1016\/j.jaad.2023.12.064 (2024).","journal-title":"J. Am. Acad. Dermatol."},{"key":"87838_CR10","doi-asserted-by":"publisher","first-page":"4905","DOI":"10.1002\/cam4.4046","volume":"10","author":"W Zhang","year":"2021","unstructured":"Zhang, W. et al. Global, regional and national incidence, mortality and disability-adjusted life-years of skin cancers and trend analysis from 1990 to 2019: An analysis of the global burden of Disease Study 2019. Cancer Med. 10, 4905\u20134922. https:\/\/doi.org\/10.1002\/cam4.4046 (2021).","journal-title":"Cancer Med."},{"key":"87838_CR11","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1046\/j.1365-2133.2001.04507.x","volume":"145","author":"MH Schmid-Wendtner","year":"2001","unstructured":"Schmid-Wendtner, M. H., Baumert, J., Wendtner, C. M., Plewig, G. & Volkenandt, M. Risk of second primary malignancies in patients with cutaneous melanoma. Br. J. Dermatol. 145, 981\u2013985. https:\/\/doi.org\/10.1046\/j.1365-2133.2001.04507.x (2001).","journal-title":"Br. J. Dermatol."},{"key":"87838_CR12","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1093\/jnci\/92.15.1260","volume":"92","author":"A Borg","year":"2000","unstructured":"Borg, A. et al. High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families. J. Natl. Cancer Inst. 92, 1260\u20131266. https:\/\/doi.org\/10.1093\/jnci\/92.15.1260 (2000).","journal-title":"J. Natl. Cancer Inst."},{"key":"87838_CR13","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1111\/bjd.18425","volume":"182","author":"YS Sheen","year":"2020","unstructured":"Sheen, Y. S. et al. Genetic alterations in primary melanoma in Taiwan. Br. J. Dermatol. 182, 1205\u20131213. https:\/\/doi.org\/10.1111\/bjd.18425 (2020).","journal-title":"Br. J. Dermatol."},{"key":"87838_CR14","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.jaad.2019.07.017","volume":"88","author":"K Shi","year":"2023","unstructured":"Shi, K. et al. Distinct genomic features in a retrospective cohort of mucosal, acral, and vulvovaginal melanomas. J. Am. Acad. Dermatol. 88, 1051\u20131059. https:\/\/doi.org\/10.1016\/j.jaad.2019.07.017 (2023).","journal-title":"J. Am. Acad. Dermatol."},{"key":"87838_CR15","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/(sici)1097-0215(19970904)72:5<776::aid-ijc12>3.0.co;2-7","volume":"72","author":"F Levi","year":"1997","unstructured":"Levi, F., La Vecchia, C., Randimbison, L., Te, V. C. & Erler, G. Incidence of invasive cancers following cutaneous malignant melanoma. Int. J. Cancer. 72, 776\u2013779. https:\/\/doi.org\/10.1002\/(sici)1097-0215(19970904)72:5<776::aid-ijc12>3.0.co;2-7 (1997).","journal-title":"Int. J. Cancer"},{"key":"87838_CR16","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/ijc.20322","volume":"111","author":"W Goggins","year":"2004","unstructured":"Goggins, W., Gao, W. & Tsao, H. Association between female breast cancer and cutaneous melanoma. Int. J. Cancer. 111, 792\u2013794. https:\/\/doi.org\/10.1002\/ijc.20322 (2004).","journal-title":"Int. J. Cancer"},{"key":"87838_CR17","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/ijc.21300","volume":"118","author":"W Goggins","year":"2006","unstructured":"Goggins, W., Daniels, G. H. & Tsao, H. Elevation of thyroid cancer risk among cutaneous melanoma survivors. Int. J. Cancer. 118, 185\u2013188. https:\/\/doi.org\/10.1002\/ijc.21300 (2006).","journal-title":"Int. J. Cancer"},{"key":"87838_CR18","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nature00766","volume":"417","author":"H Davies","year":"2002","unstructured":"Davies, H. et al. Mutations of the BRAF gene in human cancer. Nature 417, 949\u2013954. https:\/\/doi.org\/10.1038\/nature00766 (2002).","journal-title":"Nature"},{"key":"87838_CR19","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1093\/jnci\/djg123","volume":"95","author":"JL Maldonado","year":"2003","unstructured":"Maldonado, J. L. et al. Determinants of BRAF mutations in primary melanomas. J. Natl. Cancer Inst. 95, 1878\u20131890. https:\/\/doi.org\/10.1093\/jnci\/djg123 (2003).","journal-title":"J. Natl. Cancer Inst."},{"key":"87838_CR20","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/(sici)1097-0215(19991029)83:3<314::aid-ijc5>3.0.co;2-9","volume":"83","author":"C Wassberg","year":"1999","unstructured":"Wassberg, C., Th\u00f6rn, M., Yuen, J., Hakulinen, T. & Ringborg, U. Cancer risk in patients with earlier diagnosis of cutaneous melanoma in situ. Int. J. Cancer. 83, 314\u2013317. https:\/\/doi.org\/10.1002\/(sici)1097-0215(19991029)83:3<314::aid-ijc5>3.0.co;2-9 (1999).","journal-title":"Int. J. Cancer"},{"key":"87838_CR21","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3390\/cancers15020485","volume":"15","author":"S Pati","year":"2023","unstructured":"Pati, S., Irfan, W., Jameel, A., Ahmed, S. & Shahid, R. K. Obesity and cancer: A current overview of epidemiology, pathogenesis, outcomes, and management. Cancers (Basel). 15, 485. https:\/\/doi.org\/10.3390\/cancers15020485 (2023).","journal-title":"Cancers (Basel)"},{"key":"87838_CR22","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1093\/ije\/dyaa009","volume":"49","author":"JC Dusingize","year":"2020","unstructured":"Dusingize, J. C. et al. Body mass index and height and risk of cutaneous melanoma: Mendelian randomization analyses. Int. J. Epidemiol. 49, 1236\u20131245. https:\/\/doi.org\/10.1093\/ije\/dyaa009 (2020).","journal-title":"Int. J. Epidemiol."},{"key":"87838_CR23","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1093\/ije\/dyw253","volume":"46","author":"SC Seong","year":"2017","unstructured":"Seong, S. C. et al. Data resource profile: The National Health Information Database of the National Health Insurance Service in South Korea. Int. J. Epidemiol. 46, 799\u2013800. https:\/\/doi.org\/10.1093\/ije\/dyw253 (2017).","journal-title":"Int. J. Epidemiol."},{"key":"87838_CR24","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.jclinepi.2004.03.012","volume":"57","author":"V Sundararajan","year":"2004","unstructured":"Sundararajan, V. et al. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J. Clin. Epidemiol. 57, 1288\u20131294. https:\/\/doi.org\/10.1016\/j.jclinepi.2004.03.012 (2004).","journal-title":"J. Clin. Epidemiol."},{"key":"87838_CR25","doi-asserted-by":"publisher","first-page":"330","DOI":"10.4143\/crt.2022.128","volume":"54","author":"MJ Kang","year":"2022","unstructured":"Kang, M. J. et al. Cancer statistics in Korea: Incidence, mortality, survival, and prevalence in 2019. Cancer Res. Treat. 54, 330\u2013344. https:\/\/doi.org\/10.4143\/crt.2022.128 (2022).","journal-title":"Cancer Res. Treat."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87838-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87838-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87838-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T07:37:07Z","timestamp":1738049827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87838-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,28]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["87838"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-87838-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,28]]},"assertion":[{"value":"29 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Reviewed and approved by the Institutional Review Board of Asan Medical Center; approval no. 2021-0721.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was exempted from Institutional Review Board of Asan Medical Center due to the retrospective design.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"3541"}}